ED drugs ‘help stocks to rise’
May 14th, 2007 by 
Eric
The stocks of all three of the main erectile dysfunction (ED) medications are climbing, it has been reported.
Seeking Alpha has claimed that Pfizer’s Viagra, Bayer AG’s Levitra and the Eli Lilly and Company-produced Cialis are all contributing to rising stocks for their companies.
Viagra was the first drug approved to treat ED in the US and is made by the company which also manufactures Lipitor for high cholesterol and Norvasc for hypertension.
The group has one of the highest paying stocks for pharmaceuticals, with a yield of 4.3 per cent, a P/E of 10.5 and a PEG of 2.5, according to the publication.
Bayer, which produces vardenafil - known as Levitra - has a P/E of 27 and a PEG of 1.6 and pays a small yield of 1.5 per cent.
Lastly, Cialis - the chemical name of which is tadalafil - pays a divident yield of 2.9 per cent and has a P/E of 27 and a PEG of 2.3.
In related ED news, Medical News Today reported last month that users of Viagra and similar drugs must be aware of the emotional pressures as well as the physical difficulties that accompany the condition, based on the results of a report from Harvard Medical School.
Posted in Erectile Dysfunction | 